COPD Trial, Recruiting NCT06068322 Sponsor: Umeå University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06068322
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 60 years of age or older
  • People who are able to carry out everyday tasks on their own (such as dressing, eating, and moving around)
  • People with COPD who have noticeable symptoms (measured by specific breathing questionnaires) or who have not been regularly active at a moderate or high level over the past year, meaning physical activity levels fall below World Health Organization recommendations
  • People with COPD whose diagnosis has been confirmed by a breathing test (called spirometry) taken after using a bronchodilator inhaler, showing a specific result that indicates airflow limitation
  • People without any health conditions who have normal lung function (eligible to join as healthy comparison participants)

Who may not be able to join:

  • People who have unstable or serious movement, heart, nerve, muscle, bone, or joint conditions that would prevent them from safely doing exercise or tests, as determined by a doctor — this includes things like severe musculoskeletal pain, a recent heart attack or heart procedure, uncontrolled high blood pressure, or abnormal heart readings during an exercise test
  • People who have other lung conditions, such as asthma, interstitial lung disease, lung cancer, pulmonary hypertension, or pulmonary fibrosis
  • People who have medical conditions or are receiving treatments known to affect brain function or thinking, including past head injuries with lasting effects, neurological conditions (such as dementia, multiple sclerosis, or stroke), serious psychiatric illness (not including depression or general anxiety disorder), severe thinking or memory difficulties, or a recent or current cancer diagnosis and treatment
  • People with physical or mental disabilities that would affect participation (confirm with trial site)
  • People who have metal implants, pacemakers, claustrophobia, or other factors that make MRI or PET/CT scanning unsafe — this applies to those agreeing to those specific scans
  • People who are unable to read or speak Swedish (for participants at the Umeå site), Dutch or French (for participants at the Hasselt site), or English (for participants at either site)
  • People with COPD whose ability to exercise is limited more by another health condition than by their COPD itself
  • People with COPD who are currently taking part in, or have taken part in, a pulmonary rehabilitation program within the last 12 months
  • People with COPD who have had a flare-up (exacerbation) that led to a change in their medication within the past six weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: André Nyberg, PhD, Umeå University

Phone: +46 090-786 66 39

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Umeå University
Registry
ClinicalTrials.gov
Start date
9 November 2023
Est. completion
1 December 2028

Where this trial is recruiting

🇧🇪 Belgium 🇸🇪 Sweden

Primary endpoints

Change from baseline global cognitive function; Change from baseline cardiorespiratory fitness; Change from baseline quadriceps muscle power

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov